460 related articles for article (PubMed ID: 37316582)
1. The gut-liver axis and gut microbiota in health and liver disease.
Hsu CL; Schnabl B
Nat Rev Microbiol; 2023 Nov; 21(11):719-733. PubMed ID: 37316582
[TBL] [Abstract][Full Text] [Related]
2.
Huang Y; Cao J; Zhu M; Wang Z; Jin Z; Xiong Z
Microbiol Spectr; 2024 Apr; 12(4):e0339323. PubMed ID: 38411057
[TBL] [Abstract][Full Text] [Related]
3. Is intestinal inflammation linking dysbiosis to gut barrier dysfunction during liver disease?
Brandl K; Schnabl B
Expert Rev Gastroenterol Hepatol; 2015; 9(8):1069-76. PubMed ID: 26088524
[TBL] [Abstract][Full Text] [Related]
4. Dysbiosis and liver diseases (Review).
Nishikawa H; Fukunishi S; Asai A; Yokohama K; Ohama H; Nishiguchi S; Higuchi K
Int J Mol Med; 2021 Sep; 48(3):. PubMed ID: 34328191
[TBL] [Abstract][Full Text] [Related]
5. The Immune System through the Lens of Alcohol Intake and Gut Microbiota.
Calleja-Conde J; Echeverry-Alzate V; Bühler KM; Durán-González P; Morales-García JÁ; Segovia-Rodríguez L; Rodríguez de Fonseca F; Giné E; López-Moreno JA
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299105
[TBL] [Abstract][Full Text] [Related]
6. The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Albillos A; de Gottardi A; Rescigno M
J Hepatol; 2020 Mar; 72(3):558-577. PubMed ID: 31622696
[TBL] [Abstract][Full Text] [Related]
7. Effect of intestinal microbiota on liver disease and its related future prospection: From the perspective of intestinal barrier damage and microbial metabolites.
Jiang N; Xiao Y; Yuan K; Wang Z
J Gastroenterol Hepatol; 2023 Jul; 38(7):1056-1071. PubMed ID: 36662612
[TBL] [Abstract][Full Text] [Related]
8. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
9. Contribution of gut microbiota to drug-induced liver injury.
Chu HK; Ai Y; Cheng ZL; Yang L; Hou XH
Hepatobiliary Pancreat Dis Int; 2023 Oct; 22(5):458-465. PubMed ID: 37365109
[TBL] [Abstract][Full Text] [Related]
10. Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans.
Maccioni L; Gao B; Leclercq S; Pirlot B; Horsmans Y; De Timary P; Leclercq I; Fouts D; Schnabl B; Stärkel P
Gut Microbes; 2020 Nov; 12(1):1782157. PubMed ID: 32588725
[TBL] [Abstract][Full Text] [Related]
11. Alcohol, the gut microbiome, and liver disease.
Jew MH; Hsu CL
J Gastroenterol Hepatol; 2023 Aug; 38(8):1205-1210. PubMed ID: 37096652
[TBL] [Abstract][Full Text] [Related]
12. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
Rizzetto L; Fava F; Tuohy KM; Selmi C
J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
[TBL] [Abstract][Full Text] [Related]
13. The human microbiome and gut-liver axis in people living with HIV.
Duarte MJ; Tien PC; Somsouk M; Price JC
Curr HIV/AIDS Rep; 2023 Jun; 20(3):170-180. PubMed ID: 37129834
[TBL] [Abstract][Full Text] [Related]
14. Diet-Induced Gut Dysbiosis and Leaky Gut Syndrome.
Chae YR; Lee YR; Kim YS; Park HY
J Microbiol Biotechnol; 2024 Apr; 34(4):747-756. PubMed ID: 38321650
[TBL] [Abstract][Full Text] [Related]
15. Human gut microbiota/microbiome in health and diseases: a review.
Gomaa EZ
Antonie Van Leeuwenhoek; 2020 Dec; 113(12):2019-2040. PubMed ID: 33136284
[TBL] [Abstract][Full Text] [Related]
16. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
17. Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases.
Garg Y; Kanwar N; Chopra S; Tambuwala MM; Dodiya H; Bhatia A; Kanwal A
Endocr Metab Immune Disord Drug Targets; 2022; 22(14):1344-1356. PubMed ID: 35761484
[TBL] [Abstract][Full Text] [Related]
18. Modulating the gut-liver axis and the pivotal role of the faecal microbiome in cirrhosis.
Woodhouse C; Singanayagam A; Patel VC
Clin Med (Lond); 2020 Sep; 20(5):493-500. PubMed ID: 32934044
[TBL] [Abstract][Full Text] [Related]
19. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
Wang M; Zhang L; Chang W; Zhang Y
Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
[TBL] [Abstract][Full Text] [Related]
20. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
